Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Junyan Qu
Coxsackievirus Type B3 Is a Potent Oncolytic Virus Against KRAS-Mutant Lung Adenocarcinoma
Molecular Therapy - Oncolytics
Cancer Research
Oncology
Molecular Medicine
Pharmacology
Related publications
ΙκΒ Kinase Α Is Required for Development and Progression of KRAS-mutant Lung Adenocarcinoma.
Cancer Research
Cancer Research
Oncology
Immunohistochemical Loss of LKB1 Is a Biomarker for More Aggressive Biology in KRAS-Mutant Lung Adenocarcinoma
Clinical Cancer Research
Cancer Research
Oncology
P2.01-09 Targetable Genomic Alterations in KRAS Mutant Lung Adenocarcinoma by Targeted Next Generation Sequencing
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Targeting Pathways Downstream of KRAS in Lung Adenocarcinoma
Pharmacogenomics
Molecular Medicine
Genetics
Pharmacology
Seroprevalence of Coxsackievirus B3 in Yantai, China
Japanese Journal of Infectious Diseases
Medicine
Infectious Diseases
Microbiology
In Vitro Oncolytic Activity of Non-Virulent Newcastle Disease Virus LaSota Strain Against Mouse Mammary Adenocarcinoma
Iraqi Journal of Science
Genetics
Molecular Biology
Geology
Biochemistry
Computer Science
Biotechnology
Chemistry
Growth Inhibition of KRAS‑�and EGFR‑mutant Lung Adenocarcinoma by Cosuppression of STAT3 and the SRC/ARHGAP35 Axis
Oncology Reports
Medicine
Cancer Research
Oncology
Correction: CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours
PLoS ONE
Multidisciplinary
Inhibitor of Differentiation-1 (Id1) Sustains Mutant KRAS-driven Progression, Maintenance, and Metastasis of Lung Adenocarcinoma via Regulation of a FOSL1 Network
Cancer Research
Cancer Research
Oncology
